BOOSTING ONCOLOGY RESEARCH WITH INTEGRATED KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

from the speedily evolving field of oncology investigate, correct and efficient mutation screening is vital for producing targeted therapies. The KRAS Services System performs a pivotal job Within this landscape by giving detailed options for KRAS mutation profiling and Investigation. KRAS mutations, present in close to ninety five% of RAS-similar